tirzepatide injector 7.5MG Injection Package filled with a single dose of tirzepatide and are intended for subcutaneous injection (under the skin) once a week Lilly releases Zepbound® (tirzepatide) single-dose

Wegovy works by reducing appetite, improving blood sugar control, and promoting fat loss

doi: 10.1002/ijc.24028

and may interfere with blood pressure medications, among others

When the semaglutide medication Wegovy first hit the market in 2021, it became the first weight-loss drug to get FDA approval since 2014 and immediately became the go-to weight-loss treatment

Originally developed for type II diabetes, it is now widely used to help patients lose weight when combined with diet and exercise

Salbu of Georgia Institute of Technology explores a more expansive notion of public health that aims to protect people from their own dietary choices